Prognostic importance of the cause of renal failure in patients with cirrhosis - PubMed (original) (raw)
. 2011 Feb;140(2):488-496.e4.
doi: 10.1053/j.gastro.2010.07.043. Epub 2010 Aug 1.
Mónica Guevara, Aldo Torre, Claudia Fagundes, Tea Restuccia, Rosa Gilabert, Elsa Solá, Gustavo Pereira, Marcella Marinelli, Marco Pavesi, Javier Fernández, Juan Rodés, Vicente Arroyo, Pere Ginès
Affiliations
- PMID: 20682324
- DOI: 10.1053/j.gastro.2010.07.043
Free article
Prognostic importance of the cause of renal failure in patients with cirrhosis
Marta Martín-Llahí et al. Gastroenterology. 2011 Feb.
Free article
Abstract
Background & aims: The prognostic value of the different causes of renal failure in cirrhosis is not well established. This study investigated the predictive value of the cause of renal failure in cirrhosis.
Methods: Five hundred sixty-two consecutive patients with cirrhosis and renal failure (as defined by serum creatinine > 1.5 mg/dL on 2 successive determinations within 48 hours) hospitalized over a 6-year period in a single institution were included in a prospective study. The cause of renal failure was classified into 4 groups: renal failure associated with bacterial infections, renal failure associated with volume depletion, hepatorenal syndrome (HRS), and parenchymal nephropathy. The primary end point was survival at 3 months.
Results: Four hundred sixty-three patients (82.4%) had renal failure that could be classified in 1 of 4 groups. The most frequent was renal failure associated with infections (213 cases; 46%), followed by hypovolemia-associated renal failure (149; 32%), HRS (60; 13%), and parenchymal nephropathy (41; 9%). The remaining patients had a combination of causes or miscellaneous conditions. Prognosis was markedly different according to cause of renal failure, 3-month probability of survival being 73% for parenchymal nephropathy, 46% for hypovolemia-associated renal failure, 31% for renal failure associated with infections, and 15% for HRS (P < .0005). In a multivariate analysis adjusted for potentially confounding variables, cause of renal failure was independently associated with prognosis, together with MELD score, serum sodium, and hepatic encephalopathy at time of diagnosis of renal failure.
Conclusions: A simple classification of patients with cirrhosis according to cause of renal failure is useful in assessment of prognosis and may help in decision making in liver transplantation.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
- Medical management of hepatorenal syndrome.
Davenport A, Ahmad J, Al-Khafaji A, Kellum JA, Genyk YS, Nadim MK. Davenport A, et al. Nephrol Dial Transplant. 2012 Jan;27(1):34-41. doi: 10.1093/ndt/gfr736. Nephrol Dial Transplant. 2012. PMID: 22287700 Review. - Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
Huo TI, Hsu CY, Huang YH, Hsia CY, Lin HC, Lee PC, Loong CC, Chiang JH, Chiou YY, Lee SD. Huo TI, et al. Liver Int. 2010 Feb;30(2):198-207. doi: 10.1111/j.1478-3231.2009.02143.x. Epub 2009 Oct 22. Liver Int. 2010. PMID: 19849777 - Successful treatment of severe hepatorenal syndrome with living donor liver transplantation.
Demirbas BT, Piskin T, Dayangac M, Yaprak O, Oklu L, Yuzer Y, Tokat Y. Demirbas BT, et al. Hepatogastroenterology. 2012 Oct;59(119):2305-6. doi: 10.5754/hge10791. Hepatogastroenterology. 2012. PMID: 23435146 - Renal failure in cirrhosis.
Ginès P, Schrier RW. Ginès P, et al. N Engl J Med. 2009 Sep 24;361(13):1279-90. doi: 10.1056/NEJMra0809139. N Engl J Med. 2009. PMID: 19776409 Review. No abstract available. - [Renal insufficiency in liver transplantation].
Rimola A. Rimola A. Nefrologia. 2002;22 Suppl 5:69-71. Nefrologia. 2002. PMID: 12107922 Review. Spanish. No abstract available.
Cited by
- Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.
Wan YM, Huang SQ, Wu HM, Li YH, Yin HJ, Xu Y. Wan YM, et al. Front Pharmacol. 2024 Sep 4;15:1418826. doi: 10.3389/fphar.2024.1418826. eCollection 2024. Front Pharmacol. 2024. PMID: 39295934 Free PMC article. - Prognosis of Transplant-Ineligible Patients with Cirrhosis and Acute Kidney Injury Who Initiate Renal Replacement Therapy.
Diaz PM, Saly DL, Horick N, Petrosyan R, Gitto Z, Indriolo T, Li L, Kahn-Boesel O, Donlan J, Robinson B, Dow L, Liu A, El-Jawahri A, Parada XV, Combs S, Teixeira J, Chung R, Allegretti AS, Ufere NN. Diaz PM, et al. Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08623-2. Online ahead of print. Dig Dis Sci. 2024. PMID: 39215868 - Study of prevalence, risk factors for acute kidney injury, and mortality in liver cirrhosis patients.
Mohan PB, Nagaraju SP, Musunuri B, Rajpurohit S, Bhat G, Shetty S. Mohan PB, et al. Ir J Med Sci. 2024 Aug;193(4):1817-1825. doi: 10.1007/s11845-024-03663-z. Epub 2024 Mar 22. Ir J Med Sci. 2024. PMID: 38517600 Free PMC article. - From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury.
Allegretti AS, Patidar KR, Ma AT, Cullaro G. Allegretti AS, et al. Hepatology. 2024 Feb 14:10.1097/HEP.0000000000000790. doi: 10.1097/HEP.0000000000000790. Online ahead of print. Hepatology. 2024. PMID: 38353565 - Addition of Kidney Dysfunction Type to MELD-Na for the Prediction of Survival in Cirrhotic Patients Awaiting Liver Transplantation in Comparison with MELD 3.0 with Albumin.
Yeom KM, Chang JI, Yoo JJ, Moon JE, Sinn DH, Kim YS, Kim SG. Yeom KM, et al. Diagnostics (Basel). 2023 Dec 25;14(1):39. doi: 10.3390/diagnostics14010039. Diagnostics (Basel). 2023. PMID: 38201348 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical